Market Tracker

02/27 5:16pm ET

Genomic Health Inc (NASDAQ:GHDX)

30.63
Delayed Data
As of 4:00pm ET
 +0.80 / +2.68%
Today’s Change
22.00
Today|||52-Week Range
33.96
+4.22%
Year-to-Date
3 Most Wildly Overvalued Stocks in Healthcare
Feb 23 / MotleyFool.com - Paid Partner Content
Genomic Health, Inc. Swings to a Profit
Feb 15 / MotleyFool.com - Paid Partner Content
Why Genomic Health Inc. Jumped Higher Today
Feb 15 / MotleyFool.com - Paid Partner Content
Genomic Health (GHDX) Earnings Surpass Estimates in Q4
Feb 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.83
Today’s open29.76
Day’s range29.51 - 30.70
Volume135,143
Average volume (3 months)156,569
Market cap$998.7M
Dividend yield--
Data as of 4:00pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)+59.22%
Earnings growth (this year)+107.52%
Earnings growth (next 5 years)-620.03%
Revenue growth (last year)+14.06%
P/E ratioNM
Price/Sales2.98
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KANGiKang Healthcare Gro...-0.81-4.81%
FMIFoundation Medicine ...+1.07+4.65%
NEONeogenomics Inc+0.11+1.36%
NTRANatera Inc+0.21+2.16%
Data as of 4:00pm ET, 02/27/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$327.9M
Annual profit (last year)-$13.9M
Net profit margin-4.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kimberly J. Popovits
Chief Operating &
Financial Officer
G. Bradley Cole
Corporate headquarters
Redwood City, California

Forecasts